4-(4-Methylphenyl)-2-butanone
Common Name: |
4-(4-Methylphenyl)-2-butanone |
IUPAC Name: |
4-(4-methylphenyl)butan-2-one |
Molecular Formula: |
C11H14O |
SMILES: |
CC1=CC=C(C=C1)CCC(=O)C |
Inchi: |
1S/C11H14O/c1-9-3-6-11(7-4-9)8-5-10(2)12/h3-4,6-7H,5,8H2,1-2H3 |
Inchi Key: |
BUIRDOGDCJQFDA-UHFFFAOYSA-N |
Cas No: |
7774-79-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
162.23 |
Mass (g/mol) |
162.104 |
Molar Refractivity |
50.99 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
243.00 to 244.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.029 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.36 |
LogP |
2.517 |
iLOGP |
2.19 |
XLOGP3 |
2.20 |
WLOGP |
2.52 |
MLOGP |
2.69 |
ESOL Log S |
-2.40 |
ESOL Solubility (mg/ml) |
0.64 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.19 |
Ali Solubility (mg/ml) |
1.04 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.92 |
Silicos-IT Solubility (mg/ml) |
0.02 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.73 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.664 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.669 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |